Prescribing Information & Guidance
High strength, fixed combination and biosimilar insulin products: minimising the risk of medication error – Safety Reminder
Guideline added to website on: 09/06/20
Last modified on: 09/10/20
CCG: Bedfordshire | Luton
Section: Prescribing Information & Guidance
Category: Endocrinology and Diabetes
Tags: high, insulin, strength
Bulletin 240- Published June 2016
Posted in Endocrinology and Diabetes